ID   KS6A2_HUMAN             Reviewed;         733 AA.
AC   Q15349; B3KTK9; Q15419; Q59GJ3; Q5TI68; Q96J38; Q9UJN5;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   21-MAR-2006, sequence version 2.
DT   12-APR-2017, entry version 178.
DE   RecName: Full=Ribosomal protein S6 kinase alpha-2;
DE            Short=S6K-alpha-2;
DE            EC=2.7.11.1;
DE   AltName: Full=90 kDa ribosomal protein S6 kinase 2;
DE            Short=p90-RSK 2;
DE            Short=p90RSK2;
DE   AltName: Full=MAP kinase-activated protein kinase 1c;
DE            Short=MAPK-activated protein kinase 1c;
DE            Short=MAPKAP kinase 1c;
DE            Short=MAPKAPK-1c;
DE   AltName: Full=Ribosomal S6 kinase 3;
DE            Short=RSK-3;
DE   AltName: Full=pp90RSK3;
GN   Name=RPS6KA2; Synonyms=MAPKAPK1C, RSK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=7623830; DOI=10.1128/MCB.15.8.4353;
RA   Zhao Y., Bjoerbaek C., Weremowicz S., Morton C.C., Moller D.E.;
RT   "RSK3 encodes a novel pp90rsk isoform with a unique N-terminal
RT   sequence: growth factor-stimulated kinase function and nuclear
RT   translocation.";
RL   Mol. Cell. Biol. 15:4353-4363(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-540 (ISOFORM 1).
RX   PubMed=8141249;
RA   Moller D.E., Xia C.-H., Tang W., Zhu A.X., Jakubowski M.;
RT   "Human rsk isoforms: cloning and characterization of tissue-specific
RT   expression.";
RL   Am. J. Physiol. 266:C351-C359(1994).
RN   [7]
RP   ENZYME REGULATION, AND PHOSPHORYLATION AT SER-218.
RX   PubMed=10480933; DOI=10.1074/jbc.274.38.27168;
RA   Jensen C.J., Buch M.-B., Krag T.O., Hemmings B.A., Gammeltoft S.,
RA   Froedin M.;
RT   "90-kDa ribosomal S6 kinase is phosphorylated and activated by 3-
RT   phosphoinositide-dependent protein kinase-1.";
RL   J. Biol. Chem. 274:27168-27176(1999).
RN   [8]
RP   FUNCTION IN TUMORIGENESIS, AND TISSUE SPECIFICITY.
RX   PubMed=16878154; DOI=10.1038/sj.onc.1209827;
RA   Bignone P.A., Lee K.Y., Liu Y., Emilion G., Finch J., Soosay A.E.,
RA   Charnock F.M., Beck S., Dunham I., Mungall A.J., Ganesan T.S.;
RT   "RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic
RT   epithelial ovarian cancer.";
RL   Oncogene 26:683-700(2007).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   REVIEW ON FUNCTION.
RX   PubMed=18813292; DOI=10.1038/nrm2509;
RA   Anjum R., Blenis J.;
RT   "The RSK family of kinases: emerging roles in cellular signalling.";
RL   Nat. Rev. Mol. Cell Biol. 9:747-758(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-377, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] LYS-311 AND GLN-732.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase that acts downstream of
CC       ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic
CC       and stress-induced activation of transcription factors, regulates
CC       translation, and mediates cellular proliferation, survival, and
CC       differentiation. May function as tumor suppressor in epithelial
CC       ovarian cancer cells. {ECO:0000269|PubMed:16878154,
CC       ECO:0000269|PubMed:7623830}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ENZYME REGULATION: Upon extracellular signal or mitogen
CC       stimulation, phosphorylated at Thr-570 in the C-terminal kinase
CC       domain (CTKD) by MAPK1/ERK2 and MAPK3/ERK1. The activated CTKD
CC       then autophosphorylates Ser-377, allowing binding of PDPK1, which
CC       in turn phosphorylates Ser-218 in the N-terminal kinase domain
CC       (NTDK) leading to the full activation of the protein and
CC       subsequent phosphorylation of the substrates by the NTKD.
CC       {ECO:0000269|PubMed:10480933}.
CC   -!- SUBUNIT: Forms a complex with either MAPK1/ERK2 or MAPK3/ERK1 in
CC       quiescent cells. Transiently dissociates following mitogenic
CC       stimulation (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P15056:BRAF; NbExp=2; IntAct=EBI-1384149, EBI-365980;
CC       P28482:MAPK1; NbExp=4; IntAct=EBI-1384149, EBI-959949;
CC       P27361:MAPK3; NbExp=2; IntAct=EBI-1384149, EBI-73995;
CC       Q02156:PRKCE; NbExp=2; IntAct=EBI-1384149, EBI-706254;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:7623830}.
CC       Cytoplasm {ECO:0000269|PubMed:7623830}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q15349-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15349-2; Sequence=VSP_017732;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q15349-3; Sequence=VSP_041836;
CC         Note=Ref.3 (BAG53121) sequence is in conflict in position:
CC         32:E->G. Ref.3 (BAG53121) sequence is in conflict in position:
CC         34:T->A. {ECO:0000305};
CC   -!- TISSUE SPECIFICITY: Widely expressed with higher expression in
CC       lung, skeletal muscle, brain, uterus, ovary, thyroid and prostate.
CC       {ECO:0000269|PubMed:16878154, ECO:0000269|PubMed:7623830}.
CC   -!- PTM: Activated by phosphorylation at Ser-218 by PDPK1.
CC       Autophosphorylated on Ser-377, as part of the activation process.
CC       May be phosphorylated at Thr-356 and Ser-360 by MAPK1/ERK2 and
CC       MAPK3/ERK1 (By similarity). {ECO:0000250}.
CC   -!- PTM: N-terminal myristoylation results in an activated kinase in
CC       the absence of added growth factors. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. S6 kinase subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC82496.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAD92353.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAG53121.1; Type=Frameshift; Positions=527; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X85106; CAA59427.1; -; mRNA.
DR   EMBL; AB209116; BAD92353.1; ALT_INIT; mRNA.
DR   EMBL; AK095751; BAG53121.1; ALT_FRAME; mRNA.
DR   EMBL; AL022069; CAI19651.1; -; Genomic_DNA.
DR   EMBL; Z98049; CAI19651.1; JOINED; Genomic_DNA.
DR   EMBL; AL023775; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL159163; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z98049; CAI20579.1; -; Genomic_DNA.
DR   EMBL; AL022069; CAI20579.1; JOINED; Genomic_DNA.
DR   EMBL; BC002363; AAH02363.1; -; mRNA.
DR   EMBL; L07598; AAC82496.1; ALT_INIT; mRNA.
DR   CCDS; CCDS34570.1; -. [Q15349-3]
DR   CCDS; CCDS5294.1; -. [Q15349-1]
DR   CCDS; CCDS83148.1; -. [Q15349-2]
DR   PIR; A57459; A57459.
DR   RefSeq; NP_001006933.2; NM_001006932.2.
DR   RefSeq; NP_001305865.1; NM_001318936.1.
DR   RefSeq; NP_001305866.1; NM_001318937.1.
DR   RefSeq; NP_001305867.1; NM_001318938.1.
DR   RefSeq; NP_066958.2; NM_021135.5. [Q15349-1]
DR   UniGene; Hs.655277; -.
DR   ProteinModelPortal; Q15349; -.
DR   SMR; Q15349; -.
DR   BioGrid; 112110; 26.
DR   DIP; DIP-295N; -.
DR   IntAct; Q15349; 14.
DR   MINT; MINT-1542928; -.
DR   STRING; 9606.ENSP00000427015; -.
DR   BindingDB; Q15349; -.
DR   ChEMBL; CHEMBL3906; -.
DR   GuidetoPHARMACOLOGY; 1529; -.
DR   iPTMnet; Q15349; -.
DR   PhosphoSitePlus; Q15349; -.
DR   BioMuta; RPS6KA2; -.
DR   DMDM; 90110031; -.
DR   REPRODUCTION-2DPAGE; Q15349; -.
DR   MaxQB; Q15349; -.
DR   PaxDb; Q15349; -.
DR   PeptideAtlas; Q15349; -.
DR   PRIDE; Q15349; -.
DR   DNASU; 6196; -.
DR   Ensembl; ENST00000265678; ENSP00000265678; ENSG00000071242. [Q15349-1]
DR   Ensembl; ENST00000503859; ENSP00000427015; ENSG00000071242. [Q15349-3]
DR   GeneID; 6196; -.
DR   KEGG; hsa:6196; -.
DR   UCSC; uc003qvb.2; human. [Q15349-1]
DR   CTD; 6196; -.
DR   DisGeNET; 6196; -.
DR   GeneCards; RPS6KA2; -.
DR   HGNC; HGNC:10431; RPS6KA2.
DR   HPA; CAB026243; -.
DR   HPA; CAB069428; -.
DR   HPA; HPA045061; -.
DR   HPA; HPA054237; -.
DR   MIM; 601685; gene.
DR   neXtProt; NX_Q15349; -.
DR   OpenTargets; ENSG00000071242; -.
DR   PharmGKB; PA34846; -.
DR   eggNOG; KOG0598; Eukaryota.
DR   eggNOG; ENOG410XNPH; LUCA.
DR   GeneTree; ENSGT00860000133668; -.
DR   HOGENOM; HOG000233033; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; Q15349; -.
DR   KO; K04373; -.
DR   PhylomeDB; Q15349; -.
DR   TreeFam; TF313438; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   Reactome; R-HSA-198753; ERK/MAPK targets.
DR   Reactome; R-HSA-199920; CREB phosphorylation.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-437239; Recycling pathway of L1.
DR   Reactome; R-HSA-442742; CREB phosphorylation through the activation of Ras.
DR   Reactome; R-HSA-444257; RSK activation.
DR   Reactome; R-HSA-881907; Gastrin-CREB signalling pathway via PKC and MAPK.
DR   SignaLink; Q15349; -.
DR   SIGNOR; Q15349; -.
DR   ChiTaRS; RPS6KA2; human.
DR   GeneWiki; RPS6KA2; -.
DR   GenomeRNAi; 6196; -.
DR   PRO; PR:Q15349; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000071242; -.
DR   CleanEx; HS_RPS6KA2; -.
DR   ExpressionAtlas; Q15349; baseline and differential.
DR   Genevisible; Q15349; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016301; F:kinase activity; TAS:Reactome.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IDA:MGI.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0045786; P:negative regulation of cell cycle; IDA:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; NAS:ProtInc.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR016239; Ribosomal_S6_kinase_II.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 2.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000606; Ribsml_S6_kin_2; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 2.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 2.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 2.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Cytoplasm;
KW   Kinase; Magnesium; Metal-binding; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Serine/threonine-protein kinase; Transferase; Tumor suppressor.
FT   CHAIN         1    733       Ribosomal protein S6 kinase alpha-2.
FT                                /FTId=PRO_0000086201.
FT   DOMAIN       59    318       Protein kinase 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      319    388       AGC-kinase C-terminal.
FT   DOMAIN      415    672       Protein kinase 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      65     73       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     421    429       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    184    184       Proton acceptor. {ECO:0000250}.
FT   ACT_SITE    532    532       Proton acceptor. {ECO:0000250}.
FT   BINDING      91     91       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   BINDING     444    444       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     218    218       Phosphoserine; by PDPK1.
FT                                {ECO:0000269|PubMed:10480933}.
FT   MOD_RES     377    377       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   VAR_SEQ       1     32       MDLSMKKFAVRRFFSVYLRRKSRSKSSSLSRL -> MPIAQ
FT                                LLELWKKIEVEPMEIETTEEDLNLDVGPATEDTAEEGKSDS
FT                                AACKTKVAGSV (in isoform 2).
FT                                {ECO:0000303|Ref.2}.
FT                                /FTId=VSP_017732.
FT   VAR_SEQ       1     32       MDLSMKKFAVRRFFSVYLRRKSRSKSSSLSRL -> MPIAQ
FT                                LLELWKKIEVEPMEIETTEEDLNLDVEPTTEDTAE (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041836.
FT   VARIANT     311    311       E -> K (in a metastatic melanoma sample;
FT                                somatic mutation; dbSNP:rs267600891).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040627.
FT   VARIANT     732    732       R -> Q (in a colorectal adenocarcinoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs376029388).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040628.
FT   CONFLICT    256    256       S -> A (in Ref. 6; AAC82496).
FT                                {ECO:0000305}.
FT   CONFLICT    269    269       A -> S (in Ref. 6; AAC82496).
FT                                {ECO:0000305}.
FT   CONFLICT    339    339       V -> L (in Ref. 1; CAA59427 and 6;
FT                                AAC82496). {ECO:0000305}.
FT   CONFLICT    447    447       D -> G (in Ref. 6; AAC82496).
FT                                {ECO:0000305}.
SQ   SEQUENCE   733 AA;  83239 MW;  087CFB819A313760 CRC64;
     MDLSMKKFAV RRFFSVYLRR KSRSKSSSLS RLEEEGVVKE IDISHHVKEG FEKADPSQFE
     LLKVLGQGSY GKVFLVRKVK GSDAGQLYAM KVLKKATLKV RDRVRSKMER DILAEVNHPF
     IVKLHYAFQT EGKLYLILDF LRGGDLFTRL SKEVMFTEED VKFYLAELAL ALDHLHSLGI
     IYRDLKPENI LLDEEGHIKI TDFGLSKEAI DHDKRAYSFC GTIEYMAPEV VNRRGHTQSA
     DWWSFGVLMF EMLTGSLPFQ GKDRKETMAL ILKAKLGMPQ FLSGEAQSLL RALFKRNPCN
     RLGAGIDGVE EIKRHPFFVT IDWNTLYRKE IKPPFKPAVG RPEDTFHFDP EFTARTPTDS
     PGVPPSANAH HLFRGFSFVA SSLIQEPSQQ DLHKVPVHPI VQQLHGNNIH FTDGYEIKED
     IGVGSYSVCK RCVHKATDTE YAVKIIDKSK RDPSEEIEIL LRYGQHPNII TLKDVYDDGK
     FVYLVMELMR GGELLDRILR QRYFSEREAS DVLCTITKTM DYLHSQGVVH RDLKPSNILY
     RDESGSPESI RVCDFGFAKQ LRAGNGLLMT PCYTANFVAP EVLKRQGYDA ACDIWSLGIL
     LYTMLAGFTP FANGPDDTPE EILARIGSGK YALSGGNWDS ISDAAKDVVS KMLHVDPHQR
     LTAMQVLKHP WVVNREYLSP NQLSRQDVHL VKGAMAATYF ALNRTPQAPR LEPVLSSNLA
     QRRGMKRLTS TRL
//
